A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RAEB-T / RAEB in transformation

[Related PubMed/MEDLINE]
Total Number of Papers: 140
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RAEB-T  (>> Co-occurring Abbreviation)
Long Form:   RAEB in transformation
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Impact of HFE gene variants on iron overload, overall survival and leukemia-free survival in myelodysplastic syndromes. MDS, RA, RAEB, RARS
2018 Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome. FAB, Hb, MCHC, MDS, OS, RA, RAEB, RDW
2014 Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: a multicenter experience from Argentina. AHSCT, AML, DFS, GVHD, JMML, MDS, NRM, OS, RAEB, RCC
2014 [The clinical analysis of allogeneic hematopoietic stem cell transplantation from human leukocyte antigen-identical siblings in 95 patients with myelodysplastic syndrome]. aGVHD, allo-HSCT, AML, BU, cGVHD, CY, DFS, Flu, G-CSF, HLA, IPSS, MDS, NRM, OS, RA, RAEB, RR
2013 A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes. MDS, OR, RA, RAEB, RARS
2012 Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study. ECM, HSCT, RAEB
2011 Advances in the prognostication and management of advanced MDS in children. AML, HSCT, MDR-AML, MDS, RAEB
2008 High prevalence of human T-lymphotropic virus type I carriers among patients with myelodysplastic syndrome refractory anemia with excess of blasts (RAEB), RAEB in transformation and acute promyelocytic leukemia. AML, APL, CVD, HTLV-I, MDS, RA, RAEB
2008 Proliferative indices, cytogenetics, immunophenotye and other prognostic parameters in myelodysplastic syndromes. CMML, IPSS, MDS, RA, RAEB, RARS
10  2006 Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations. MDS, RAEB, RTK
11  2006 Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category. CMML, FAB, RA, RAEB, RARS, VEGF
12  2006 Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS. AML, MDS, RAEB
13  2006 Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome. AML, MDS, RAEB
14  2006 Unusual complex hyperdiploid karyotypes in myelodysplastic syndromes. MDS, RA, RAEB
15  2006 [Allogenic stem cell transplantation from genotypically HLA-identical siblings for 30 patients with myelodysplastic syndromes]. allo-HSCT, BMT, DFS, MDS, OS, PBSCT, RA, RAEB, RARS
16  2005 Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. IPSS, MDS, RA, RAEB, RARS
17  2005 Risk factors of myelodysplastic syndromes: a case-control study. CMML, FAB, MDS, OR, RA, RAEB, RARS
18  2004 Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. BMT, CMML, EFS, JMML, MDS, RA, RAEB, RARS
19  2004 Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases. BMA, BMB, MDS, PB, RA, RAEB
20  2004 Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance. CMML, IL-1beta, MDS, RA, RAEB, RARS, sICAM-1, sVCAM-1
21  2004 Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome. IC, MDS, RAEB
22  2004 Transformation of myelodysplastic syndromes into acute myeloid leukemias. AML, MDSs, RA, RAEB
23  2004 [Clinical and cytogenetic features of 29 cases of myelodysplastic syndrome associated with del(20q)]. MDS, RA, RAS
24  2004 [Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis]. BMMNCs, DDIT3, ETV1, GSPT1, MAD, MDS, PTEN, RA, RAEB, RNAHP, RTC, THBS1
25  2003 Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. CI, CMML, DFS, GVHD, MDS, OS, PBSC, RA, RAEB, sAML, TRM
26  2003 Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. FADD, MDS, RA, RAEB, RIP, RT, TNF, TNFR, TRADD, TRAF-2
27  2003 Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes. AML, CR, CRp, i.v, MDR, RAEB, VOD
28  2003 High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. MDS, RAEB
29  2003 Immunohistochemical study of T lymphocyte subsets on frozen substituted plastic embedding section of the bone marrow from patients with myelodysplastic syndrome and its clinical implication. MDS, RAEB
30  2003 Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes. FAB, HCT, MDS, RA, RAEB
31  2003 [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome]. AML, MDS, RA, RAEB, RAS
32  2003 [Wilms' tumor-1 gene expression in myelodysplastic syndrome and its changes in the process of myelodysplastic syndrome transforming into acute leukemia]. AL, MDS, RA, RAEB, RT-PCR, WT1
33  2002 Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology. AML, HLA, IL-10, LTalpha, MDS, RA, RAEB, TNF-alpha
34  2002 Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes. AML, BMMNC, EPO, IL-3, MDS, RA, RAEB, RT-PCR, SCF
35  2002 Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes. BMMNC, CMML, IPSS, MDS, RA, RAEB, RAS
36  2002 Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality. CI, CMML, FAB, IPSS, MDS, NRM, RAEB
37  2002 Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies. ALL, AML, CML, MDS, RA, RAEB
38  2002 Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. AML, BMT, JMML, MDS, RA, RAEB
39  2002 Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99. AML, RAEB
40  2002 Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. CI, MDS, OR, RA, RAEB, RR, TRM
41  2001 Expression and activity of caspases 1 and 3 in myelodysplastic syndromes. CMML, MDS, RA, RAEB, RAS
42  2001 [Apoptosis and proliferative activity of bone marrow cells in patients with aplastic syndromes as evidenced by trephine biopsy]. ANLL, CsA, LGM, RA, RAEB
43  2001 [Refractory anemia and preleukemia: an analysis of 92 cases]. AL, PL, RAEB
44  2000 A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes. CMMoL, HRMDS, LD Ara-C, RAEB
45  2000 Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro. RA, RARS, TUNEL
46  2000 Allogeneic bone marrow transplantation for children with myelodysplastic syndrome. ATG, BMT, CMML, FAB, GVHD, RAEB
47  2000 Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients. AML, CMML, MDS, RAEB
48  2000 Differential cellular expression of the human MSH2 protein in normal and myelodysplastic haematopoiesis. hMSH2, MDS, RA, RAEB, RARS
49  2000 Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels. ANC, MDS, RA, RAEB, TNF
50  2000 Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes. AML, CMMoL, MDS, RA, RAEB, RARS
51  2000 Neutrophil-specific reduction in the expression of granulocyte--macrophage colony-stimulating factor receptor subunits in myelodysplastic syndromes. GM-CSF, GMR alpha, MDS, RA, RAEB, RARS
52  2000 The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. MDS, RA, RAEB, RARS
53  2000 Thrombopoietin and myelodysplastic syndromes. MDS, RA, RAEB, TPO, TPO-R
54  2000 Treatment with low-dose cytosine arabinoside followed by administration of macrophage colony-stimulating factor prolongs the survival of patients with RAEB, RAEB-T, or leukemic phase myelodysplastic syndrome: a pilot study. LDAraC, M-CSF, MDS, RAEB
55  1999 Biologic characteristics of 164 patients with myelodysplastic syndromes. BM, ISEL, MDS, RA, RAEB, RARS, TNF-alpha
56  1999 Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes. MDS, MK, RA, RAEB, RARS
57  1999 Chromosome 11 abnormalities in myelodysplastic syndromes. CMMoL, FAB, MDS, RA, RAEB
58  1999 Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome. BMMNC, MDS, RAEB
59  1999 Importance of basophilia in haematopoietic disorders. MDS, NAP, RAEB
60  1999 Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). AML, BMT, EWOG-MDS, JMML, MDS, RA, RAEB
61  1999 The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. AML, BM, MDS, PB, RA, RAEB
62  1999 WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia. ALL, AML, MDS, RA, RAEB
63  1998 A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. FasL, MDS, RA, RAEB
64  1998 Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome. AML, CMML, MDS, PCR-ASO, RA, RAEB, RARS
65  1998 Diagnostic and biological significance of sideroblastic erythropoiesis in the myelodysplastic syndromes. AISA, RAEB, RS
66  1998 Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes. MDS, RA, RAEB, TPO, TPO-R
67  1998 Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia. AML, MDS, RA, RAEB, RARS, TUNEL
68  1998 [Cytogenetic study of 93 myelodysplastic syndromes]. MDS, RAEB, RARS
69  1997 Anti-Leukemia Chemotherapy of High-Risk Myelodysplastic Syndromes. CMMoL, CR, MDS, NR, PR
70  1997 Hypermethylation of the p15INK4B gene in myelodysplastic syndromes. CDKI, MDS, RA, RAEB, RARS
71  1997 Interphase ribosomal RNA cistron silver staining in refractory anaemias with and without excess blasts. MDS, RA, RAEB
72  1997 Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome. BM, MDS, RAEB
73  1997 Susceptibility to Infection Due to Diminished Interferon-alpha-Producing Capacity in Patients with Refractory Anemia with Excess of Blasts or Refractory Anemia with Excess of Blasts in Transformation. IFN, RAEB
74  1997 Telomere length in myelodysplastic syndromes. CMMLt, MDS, RA, RAEB, TRA
75  1997 The Myelodysplastic Syndromes. AML, MDS, RAEB
76  1997 Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children. BMT, GVHD, JCML, RA, RAEB
77  1996 Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors. BU, CMML, CY, DFS, HLA, RAEB, TBI
78  1996 Low-dose melphalan for treatment of high-risk myelodysplastic syndromes. CR, MDS, RAEB
79  1996 Prognostic factors in myelodysplastic syndromes: critical analysis of the impact of age and gender and failure to identify a very-low-risk group using standard mortality ratio techniques. CMML, MDS, RA, RAEB, SMR
80  1995 Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare. CMML, JPN, MDS, RA, RAEB, RARS
81  1995 Double-minute chromosomes appearing in a patient with myelodysplastic syndrome with disease evolution. dmin, MDS, RAEB
82  1995 Prognostic factors in myelodysplastic syndromes: analysis of five scoring systems. AL, CMML, MDS, RA, RAEB, RSA
83  1995 Prognostic value of c-mpl expression in myelodysplastic syndromes. CMML, GPIIb, RA, RAEB, RARS, TPO
84  1995 Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia. AA, MDS, PBMC, RA, RAEB
85  1995 [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome]. CMMoL, MDS, RA, RAEB, RARS
86  1995 [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate]. MDS, RAEB, WBC
87  1994 Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. BMT, MDSs, MLC, RAEB
88  1994 CD 34 immunotyping of blasts in myelodysplasia. CMML, PMC, RAEB
89  1994 Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases. AML, MDS, RA, RAEB, RARS
90  1994 Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival. AL, CMML, MDS, RA, RAEB, RARS
91  1994 Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes. AML, G-CSF, MDS, RAEB
92  1994 Secondary myelodysplastic syndrome in multiple myeloma--a study of nine patients with an attempt to detect myeloma patients at risk. MM, RA, RAEB, sMDS
93  1994 [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes]. CMML, MDS, PT, RA, RAEB, TF
94  1993 5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromes. BM, MDS, PB, RAEB
95  1993 A randomized phase II trial of low-dose aclarubicin vs very low-dose cytosine arabinoside for treatment of myelodysplastic syndromes. GR, LC-ACR, MDS, PR, RA, RAEB, VLD-AC
96  1993 Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): a pilot study. ABMT, AML, CMML, CR, MDS, RAEB
97  1993 Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. CMML, HPRT, MDS, PGK, RA, RAEB, RARS, RFLP
98  1993 Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites. ANLL, ET, MDS, PRV, RA, RAEB, RARS
99  1993 Immunotyping of blasts in refractory anaemia with excess of blasts. RAEB
100  1993 Relationship between autoantibody and dermatosis in myelodysplastic syndrome. ANA, CMMoL, MDS, RA, RAEB, RARS, RF